Announcements Trials
Browse Landscape

Phase

Phase NA 97Phase 2 8Phase 2/3 5Phase 3 3Phase 1/2 3Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 154Carboplatin 146Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 118Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Palliative Care × Clear all
NCT00047073 2020-08-03

Sirolimus in Treating Patients With Glioblastoma Multiforme

Jonsson Comprehensive Cancer Center

Phase 1/2 Completed
13 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT02655913 2018-11-30

VCONSCLC

Clifford Hospital, Guangzhou, China

Phase 1/2 Completed
97 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01392131 2012-12-12

Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC)

Clinical Research Organization, Dhaka, Bangladesh

Phase 1/2 Unknown
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡